I'd consider that a pass mark with everything inline with the revised guidance from back in April and an exciting future with some of the new EOS products.
- Forums
- ASX - By Stock
- EOS
- Ann: Activity Statement and Appendix 4c
Ann: Activity Statement and Appendix 4c, page-2
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EOS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.29 |
Change
-0.045(3.37%) |
Mkt cap ! $248.9M |
Open | High | Low | Value | Volume |
$1.33 | $1.36 | $1.29 | $597.0K | 451.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3534 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 3156 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3534 | 1.290 |
1 | 3155 | 1.285 |
5 | 14452 | 1.280 |
1 | 392 | 1.275 |
3 | 4564 | 1.270 |
Price($) | Vol. | No. |
---|---|---|
1.310 | 3156 | 1 |
1.315 | 3156 | 1 |
1.350 | 3803 | 1 |
1.385 | 10000 | 1 |
1.395 | 12797 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
EOS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online